Clinical trial
Cyclophosphamide in Treating Young Patients With Severe Autoimmune Enteropathy
NCT00258180 · Johns Hopkins University, Other · Completed
Key facts
| NCT number | NCT00258180 |
|---|---|
| Title | Cyclophosphamide in Treating Young Patients With Severe Autoimmune Enteropathy |
| Official title | High-Dose Cyclophosphamide for the Treatment of Severe Autoimmune Enteropathy |
| Lead sponsor | Johns Hopkins University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diarrhea, Gastrointestinal Complications, Unspecified Childhood Solid Tumor, Protocol Specific |
| Intervention type | Biological, Drug |
| Interventions | filgrastim, cyclophosphamide |
| Enrollment | 3 |
| Start date | Aug 15, 2005 |
| Primary completion | Feb 24, 2009 |
| Completion | Feb 24, 2009 |
| First posted | Nov 24, 2005 |
| Last update posted | Apr 16, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: